Medicare Enrolled
Dr. John Vine, M.D.
Dermatology · Princeton, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vine from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vine?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vine
Dr. John Vine is a dermatology specialist in Princeton, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Vine performed 2,825 Medicare services across 1,883 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vine received a total of $7,861 from 43 pharmaceutical and/or device companies across 521 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vine is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 43% volume in NJ
$7,861 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,825
Medicare services
Top 43% in NJ for dermatology
1,883
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~141 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
947 | $99 | $200 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
446 | $6 | $35 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
280 | $43 | $175 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
255 | $84 | $240 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
205 | $85 | $265 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
110 | $151 | $500 |
| Shaving of skin growth, 1.1-2.0 cm This procedure involves shaving off a skin growth measuring between 1.1 and 2.0 centimeters from the body, arms, or legs. |
106 | $107 | $275 |
| Shaving of skin growth, 1.1-2.0 cm Removal of a skin growth by shaving the surface of the skin. The procedure is performed on the face, ears, eyelids, nose, lips, or mouth and involves a lesion measuring between 1.1 and 2.0 centimeters. |
99 | $127 | $290 |
| Home visit, established patient, low complexity A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes. |
68 | $56 | $150 |
| Shaving of skin growth, 1.1-2.0 cm Removal of a skin growth by shaving the surface. The procedure is performed on the scalp, neck, hands, feet, or genitals and involves a lesion measuring between 1.1 and 2.0 centimeters. |
51 | $106 | $280 |
| Destruction of skin growth, 15 or more growths | 40 | $112 | $300 |
| Shaving of skin growth, more than 2.0 cm Removal of a skin growth by shaving the surface with a blade. This procedure is performed on the body, arms, or legs when the growth exceeds 2.0 centimeters. |
36 | $124 | $310 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $79 | $150 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
25 | $93 | $275 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
21 | $1 | $5 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
16 | $104 | $260 |
| Shaving of skin growth, larger than 2.0 cm This procedure involves the removal of a skin growth by shaving it off. It is performed on areas such as the scalp, neck, hands, feet, or genitals when the growth exceeds 2.0 cm in size. |
16 | $122 | $310 |
| Shaving of skin growth on face or mouth, larger than 2.0 cm This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The growth being removed is larger than 2.0 centimeters in size. |
16 | $161 | $360 |
| Skin and tissue removal, 20 sq cm or less This procedure involves the surgical excision of skin and underlying tissue from an area measuring 20 square centimeters or smaller. |
15 | $114 | $200 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
14 | $137 | $360 |
| Home visit, new patient, low complexity A home visit for a new patient involving a low level of medical decision making. The visit lasts at least 30 minutes when time is used to determine the level of service. |
14 | $52 | $240 |
| Destruction of cancerous skin growth, 2.1-3.0 cm This procedure involves the removal or destruction of a cancerous skin lesion measuring between 2.1 and 3.0 centimeters located on the trunk, arms, or legs. |
11 | $167 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,861
Total received (2018-2024)
Avg $1,123/year across 7 years
Top 21% in NJ for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
521
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,861 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,053
2023
$1,445
2022
$1,477
2021
$1,260
2020
$1,169
2019
$802
2018
$655
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
MAYNE PHARMA COMMERCIAL LLC
$242
E.R. Squibb & Sons, L.L.C.
$165
Galderma Laboratories, L.P.
$140
REVANCE THERAPEUTICS, INC.
$83
Arcutis Biotherapeutics, Inc.
$65
Fidia Pharma USA Inc.
$60
Incyte Corporation
$49
Novartis Pharmaceuticals Corporation
$49
Verrica Pharmaceuticals Inc.
$48
Ortho Dermatologics, a division of Bausch Health US, LLC
$31
Organogenesis Inc.
$21
ConvaTec Inc.
$18
Almirall LLC
$18
PFIZER INC.
$18
GENZYME CORPORATION
$17
Journey Medical Corporation
$16
STRATA Skin Sciences, Inc.
$14
Top 3 companies account for 52.0% of 2024 payments
All-time payments by company (2018-2024) ›
Ortho Dermatologics, a division of Bausch Health US, LLC
$884
LEO Pharma Inc.
$763
Merz North America, Inc.
$529
MAYNE PHARMA INC.
$523
MAYNE PHARMA COMMERCIAL LLC
$517
Almirall LLC
$496
VYNE Pharmaceuticals Inc.
$437
Sun Pharmaceutical Industries Inc.
$388
Mayne Pharma Inc.
$384
Galderma Laboratories, L.P.
$337
EPI Health, LLC
$298
E.R. Squibb & Sons, L.L.C.
$251
Arcutis Biotherapeutics, Inc.
$228
PFIZER INC.
$216
Incyte Corporation
$209
SUN PHARMACEUTICAL INDUSTRIES INC.
$113
Journey Medical Corporation
$98
ABBVIE INC.
$86
Verrica Pharmaceuticals Inc.
$84
REVANCE THERAPEUTICS, INC.
$83
Janssen Biotech, Inc.
$81
Sebela Pharmaceuticals Inc.
$75
AbbVie Inc.
$72
DERMIRA, INC.
$71
Biofrontera Inc.
$71
Fidia Pharma USA Inc.
$60
Mission Pharmacal Company
$50
Novartis Pharmaceuticals Corporation
$49
Regeneron Healthcare Solutions, Inc.
$48
Organogenesis Inc.
$47
GENZYME CORPORATION
$44
ORGANOGENESIS INC.
$43
Amgen Inc.
$34
Encore Dermatology Inc.
$28
Taro Pharmaceuticals USA, Inc.
$26
STRATA Skin Sciences, Inc.
$25
ConvaTec Inc.
$18
Integra LifeSciences Corporation
$17
Dermavant Sciences, Inc.
$16
TRIAD LIFE SCIENCES INC.
$15
Lilly USA, LLC
$15
Allergan Inc.
$14
Promius Pharma LLC
$13
Top 3 companies account for 27.7% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA LD · ADBRY · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · ATOPICLAIR NON-STEROID · Absorica LD · Ameluz · Avar · BOTOX COSMETIC · BRYHALI · CLODERM · COSENTYX · CYGNUS DUAL · Cabtreo · DAXXIFY · DORYX · DUOBRII · DUPIXENT · DYSPORT · ENSTILAR · EPIDUO FORTE · EUCRISA · FINACEA · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · HYLATOPIC EMOLLIENT · INNOVAMATRIX AC · Impoyz · Integra · JUBLIA · LIBTAYO · NAFTIN · OPZELURA · Otezla · PRAMOSONE · Puraply · Puraply Antimicrobial · QBREXZA · REMICADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · Sernivo Spray · Seysara · Sitavig · Sotyktu · TALTZ · TREMFYA · TWYNEO · USP) 0.1% · VTAMA · Veltin · Winlevi · XEOMIN · XTRAC · Xeomin · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Dermatologists within 10 mi
107
Per 100K population
27.9
County median income
$96,333
Nearest hospital
UNIVERSITY MEDICAL CENTER OF PRINCETON AT PLAINSBORO
4.3 mi
4.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vine is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vine experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Vine performed 947 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vine receive payments from pharmaceutical companies?
Yes. Dr. Vine received a total of $7,861 from 43 companies across 521 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vine's costs compare to other dermatologists in Princeton?
Dr. Vine's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vine) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Princeton
Browse dermatologists in Princeton ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in NJ
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in NJ
Which NJ dermatologists receive the most from drug and device companies.
By company
Ortho Dermatologics, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Ortho Dermatologics, a division of Bausch Health US, LLC.
By company
LEO Pharma Inc. Payments to Doctors
See all physicians who received payments from LEO Pharma Inc.
By company
Merz North America, Inc. Payments to Doctors
See all physicians who received payments from Merz North America, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology